Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis [PDF]
P. Riley+5 more
openalex +1 more source
RITUXIMAB IN PEDIATRIC RHEUMATOLOGY
The article presents literature review on the role of B-lymphocytes in pathogenesis of rheumatologic diseases and on the administration of chimeric anti-CD20 monoclonal antibodies — rituximab — for treatment of systemic lupus erythematosus, systemic ...
E.I. Alexeeva+4 more
doaj
Central nervous system complications in two cases of juvenile onset dermatomyositis
A. V. Ramanan+2 more
openalex +1 more source
8.3 Disease patterns in Danish Juvenile Dermatomyositis patients [PDF]
PR Mathiesen+3 more
openalex +1 more source
Treatment of refractory juvenile dermatomyositis with tacrolimus [PDF]
Jihaan Hassan+2 more
openalex +1 more source
EXERCISE TOLERANCE IN PATIENTS WITH JUVENILE DERMATOMYOSITIS.
Tim Takken+4 more
openalex +1 more source
8.4 Novel autoantibodies targeting a p140 protein are a major autoantigen system in juvenile dermatomyositis and a marker of calcinosis [PDF]
Harsha Gunawardena+8 more
openalex +1 more source
3.5 Comparison of functional ability in juvenile idiopathic arthritis, juvenile dermatomyositis, juvenile systemic lupus erythematosus and healthy controls. An analysis of the PRINTO database [PDF]
Giovanni Filocamo+11 more
openalex +1 more source
Myeloid cells which secrete S100 proteins in juvenile dermatomyositis may contribute to disease activity [PDF]
Hemlata Varsani+4 more
openalex +1 more source